Enrolling 1,000 Patients

May 21, 2020

Enrolling 1,000 Patients

Clinical testing has begun on Gilead’s antiviral drug remdesivir coupled with baricitinib, an anti-inflammatory medicine. The enrollment of more than 1,000 participants is ongoing. In addition to supporting clinical trials, Yourway can also provide all ancillary materials needed during a trial, no matter how large the scale.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

SCOPE Supply Chain & Logistics Leadership Summit

February 2-5, 2026
Orlando, Florida

Schedule a Meeting

Clinical Trial Supply Europe

February 24-26, 2026
Hyatt Regency, Barcelona Tower

Schedule a Meeting

Media

Articles

Why Alignment Matters in Clinical Logistics

Open chat

Hello! How can I help you?